Humana Inc (NYSE:HUM) – Jefferies Group increased their Q1 2018 EPS estimates for shares of Humana in a note issued to investors on Thursday. Jefferies Group analyst D. Windley now expects that the insurance provider will earn $3.21 per share for the quarter, up from their prior estimate of $3.11. Jefferies Group currently has a “Buy” rating and a $221.00 target price on the stock. Jefferies Group also issued estimates for Humana’s Q2 2018 earnings at $4.00 EPS, Q3 2018 earnings at $4.04 EPS and FY2019 earnings at $16.65 EPS.
Several other equities research analysts have also recently commented on the stock. Credit Suisse Group raised shares of Humana from a “neutral” rating to an “outperform” rating and cut their price target for the stock from $264.90 to $246.00 in a research report on Thursday. Leerink Swann increased their price target on shares of Humana from $280.00 to $300.00 and gave the company an “outperform” rating in a report on Thursday. Oppenheimer increased their price target on shares of Humana from $275.00 to $305.00 and gave the company an “outperform” rating in a report on Thursday. ValuEngine lowered shares of Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, December 19th. Finally, Zacks Investment Research lowered shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 17th. Eight equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $268.26.
Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.00 by $0.06. Humana had a net margin of 4.55% and a return on equity of 16.13%. The company had revenue of $13.19 billion during the quarter, compared to analyst estimates of $13.14 billion. During the same quarter in the previous year, the business earned $2.34 EPS. The firm’s revenue was up 2.4% on a year-over-year basis.
Humana declared that its Board of Directors has authorized a share repurchase program on Thursday, December 14th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the insurance provider to buy shares of its stock through open market purchases. Shares buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.
The firm also recently declared a quarterly dividend, which will be paid on Friday, April 27th. Stockholders of record on Friday, March 30th will be paid a dividend of $0.50 per share. The ex-dividend date is Wednesday, March 28th. This represents a $2.00 annualized dividend and a dividend yield of 0.76%. This is an increase from Humana’s previous quarterly dividend of $0.40. Humana’s dividend payout ratio (DPR) is presently 9.59%.
In other news, SVP Brian P. Leclaire sold 1,679 shares of the firm’s stock in a transaction on Thursday, December 21st. The shares were sold at an average price of $245.97, for a total transaction of $412,983.63. Following the completion of the transaction, the senior vice president now owns 9,888 shares of the company’s stock, valued at $2,432,151.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Jody L. Bilney sold 7,054 shares of the firm’s stock in a transaction on Monday, December 18th. The shares were sold at an average price of $247.89, for a total transaction of $1,748,616.06. Following the transaction, the senior vice president now directly owns 11,704 shares of the company’s stock, valued at approximately $2,901,304.56. The disclosure for this sale can be found here. Insiders have sold 10,115 shares of company stock valued at $2,501,627 in the last ninety days. Insiders own 0.80% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in HUM. Janus Henderson Group PLC raised its stake in shares of Humana by 74.1% during the third quarter. Janus Henderson Group PLC now owns 2,729,248 shares of the insurance provider’s stock valued at $664,921,000 after acquiring an additional 1,161,661 shares during the last quarter. Koch Industries Inc. bought a new position in shares of Humana during the second quarter valued at $404,000. APG Asset Management N.V. raised its stake in shares of Humana by 60.3% during the fourth quarter. APG Asset Management N.V. now owns 729,519 shares of the insurance provider’s stock valued at $150,709,000 after acquiring an additional 274,435 shares during the last quarter. Bank of Montreal Can raised its stake in Humana by 118.3% during the fourth quarter. Bank of Montreal Can now owns 501,379 shares of the insurance provider’s stock worth $124,378,000 after buying an additional 271,701 shares during the last quarter. Finally, Old Mutual Global Investors UK Ltd. raised its stake in Humana by 127.4% during the third quarter. Old Mutual Global Investors UK Ltd. now owns 441,325 shares of the insurance provider’s stock worth $107,520,000 after buying an additional 247,237 shares during the last quarter. 94.39% of the stock is owned by hedge funds and other institutional investors.
WARNING: “Humana Inc to Post Q1 2018 Earnings of $3.21 Per Share, Jefferies Group Forecasts (HUM)” was first posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was copied illegally and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece can be viewed at https://www.americanbankingnews.com/2018/02/09/humana-inc-to-post-q1-2018-earnings-of-3-21-per-share-jefferies-group-forecasts-hum.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.